The In Vitro Diagnostics (IVD) market represents one of the most lucrative segments in the global healthcare industry. Various factors, such as increasing prevalence of several chronic and infectious diseases, emerging technologies and increasing patient awareness, continue to fuel growth in global IVD market. With increasing technological advancements in global diagnostic market, the worldwide IVD market is estimated to grow by around 8% in 2009 over 2008.
According to our latest research report, “Global In Vitro Diagnostic Market Analysis”, the global IVD market is forecast to grow at a CAGR of around 9% during 2010-2012. Currently, the IVD market is particularly characterized by the emergence of various novel technologies, with molecular diagnostics and point of care tests expected to play a very important role in driving the future growth of the market worldwide. In terms of disease testing, blood glucose monitoring and cancer testing segments are expected to dominate the market in near future. Besides this, influenza diagnostic market is also expected to play a significant role in the development of the industry.
We have done extensive research in order to identify current trends in the key markets worldwide. We have found that the current IVD market continues to be dominated by point-of-care test segment, while the molecular diagnostic segment recorded higher growth rate in 2008. The molecular diagnostic market is anticipated to grow at a CAGR of around 14% during 2010-2012. In this regard, our report provides rational analysis of various factors which will drive this market segment over the forecast period.
The report also provides extensive information on the traditional IVD testing markets as well as on the emerging technologies. Also, an insight of trends prevailing in the regional IVD markets across the globe has been covered in the report. Analysis and statistics regarding market size, growth, share, segmentation and geographic distribution and trends in technology development have been thoroughly studied in the report to give a comprehensive view of the IVD market.
